In the trials including patients with mild-to-moderate disease, there was a trend towards increased mortality, though it did not reach statistical significance [ 9 , 10 , 23 ].
← all excerpts
Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis.
1
—
—